You have 9 free searches left this month | for more free features.

Condition

Metastatic Colorectal Cancer (1)

Pancreatic Cancer (1)

Peripheral T Cell Lymphoma (1)

Relapse/Recurrence (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 2/phase 3 (1)

Sponsor

Oslo University Hospital (1)

The Lymphoma Academic Research Organisation (1)

Unidad Integral de Investigacion en Oncologia S.L. (1)

Collaborator

Haukeland University Hospital (1)

Helse Stavanger HF (1)

Hoffmann-La Roche (1)

Innate Pharma (1)

St. Olavs Hospital (1)

University Hospital of North Norway (1)

Intervention

oxaliplatine (3)

5-fu (1)

bevacizumab (1)

capecitabine (1)

gemcitabine (1)

irinotecan (1)

lacutamab (1)

pancreatic surgery (1)

Study Documents

Intervention Type

drug (3)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (3)

oxaliplatine

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pancreatic Cancer Trial in Worldwide (5-FU, Oxaliplatine, Irinotecan)

Active, not recruiting

Pancreatic Cancer

5-FU
+3 more

Odense, Denmark
+12 more

Jun 25, 2021

Peripheral T Cell Lymphoma, Relapse/Recurrence Trial in Belgium, France (Lacutamab, Gemcitabine, Oxaliplatine)

Recruiting

Peripheral T Cell Lymphoma
Relapse/Recurrence

Lacutamab
+2 more

Antwerpen, Belgium
+38 more

Dec 6, 2021

Metastatic Colorectal Cancer Trial in Madrid (Bevacizumab, Capecitabine, Oxaliplatine)

Completed

Metastatic Colorectal Cancer

Bevacizumab
+2 more

Madrid, Spain

Hospital 12 de Octubre

Aug 23, 2011